Distributor inventory | Tablet
Tofacitinib 5 mg
Treatment of rheumatoid arthritis (moderate to severe) in adults, psoriatic arthritis in adults, ulcerative colitis (moderate to severe) in adults (as prescribed by specialist)
Tofacitinib is a Janus kinase (JAK) inhibitor. It blocks JAK-mediated signaling of inflammatory cytokines, thereby reducing immune activation, inflammation, pain, and joint/intestinal symptoms.
Tablet for oral use. Take exactly as prescribed by the doctor, usually 5 mg once or twice daily depending on indication. Can be taken with or without food; swallow whole with water at the same time each day. Do not stop or change dose without medical advice.
Common side effects of TOFASURE 5MG TAB may include:
Prescription-only immunosuppressant. Increased risk of serious infections (TB, fungal, bacterial, viral) and reactivation of TB/hepatitis; screening may be needed before starting. Risk of blood clots (DVT/PE), major cardiovascular events, and malignancy may increase in some patients—use lowest effective dose and follow specialist advice. Monitor CBC, liver enzymes, lipids; watch for signs of infection. Use caution in liver/kidney impairment. Avoid live vaccines during treatment.
